"Bitcoin isn't backed by anything."
Let me stop you right there.
Bitcoin is backed by energy. Real energy. Kilowatts. Heat. Physics.
The kind of backing you can't print, fake, or vote into existence at an emergency Fed meeting.
Every block mined is a thermodynamic proof of work. Not a promise. Not a policy. Proof.
The issuance schedule has never been amended by a committee. Not once. Not ever. Because there is no committee.
There's just math. Cold, indifferent, and immune to political theater.
The network is secured by more raw computing power than anything humanity has ever built. Hundreds of exahashes per second standing guard. Every single day.
Now let's talk about what is backed by nothing.
The dollar.
It's is backed by confidence. Specifically, confidence in the institution that printed $6 trillion in two years while telling you 3% inflation was healthy and you should be grateful for the soft landing.
In the same people who can't pass an audit.
Who fund wars with a credit card.
Who promise solvency while sitting on $39 trillion in debt and accelerating.
"Backed by nothing" isn't an attack on Bitcoin.
It's a confession about the dollar.
Follow if you're serious about building wealth they can't print away.
Gerçek ralli kimsenin konforlu olmadığı yerden başlar.
Bitcoin’de herkes 80.000 ve üzerini konuşuyor ama aşağıda hâlâ alınmamış ciddi bir likidite var.
67.000 bölgesindeki CME gap bu işin ana parçası. Bu tarz alanlar temizlenmeden gelen yükselişler genelde sürdürülebilir olmaz.
Orası alındığında piyasa hem yakıt toplar hem de sonraki hareket çok daha sağlıklı olur.
Ana akım diyet ve fitness dünyası, günümüzde otofajiyi (hücrenin kendi kendini yemesi/sindirmesi) aralıklı oruçla, açlıkla veya çeşitli takviyelerle tetiklenmesi gereken mucizevi bir gençleşme ve arınma yöntemi olarak pazarlasa da durum tam tersidir.
Otofajiyi aç kalarak veya ++
🚨 IMPOSSIBLE JUST BECAME REAL IN REGENERATIVE ORTHOPEDICS:
Scientists just supercharged cartilage repair by amplifying mitochondria 854x — turning exhausted joint cells into collagen powerhouses that rebuild full load-bearing cartilage in animal OA models in weeks! 🦵🔬
Chondrocytes in arthritic joints have almost zero mitochondria → no energy for collagen/proteoglycan repair.
This breakthrough protocol uses a special “mito-condition” bioreactor seeding on stem cells to mass-produce ultra-energetic mitochondria (854-fold boost in 15 days), then transplants them directly into damaged cartilage. Result?
Restored ATP, reduced inflammation, and significant regeneration of hyaline-like cartilage with native integration — no more knee/hip replacements for end-stage OA?
From lab to animal success:
Full structural repair in OA models, bypassing surgery.
Human clinical trials slated for late 2026.
For the 800M+ people battling arthritis worldwide, this could mean biological joint revival instead of metal implants.
Mind-blown? 🤯
RT if you’d trade surgery for this energy-boost therapy! ❤️
#CartilageRegeneration #OsteoarthritisCure #MitochondriaTherapy #RegenerativeMedicine #JointRepair
Verified sources for the 854x mitochondrial amplification & cartilage regeneration breakthrough (Zhejiang University, published March 2025 in Bone Research):
• Official EurekAlert/News Release (March 31, 2025): https://t.co/Dv37c65T4L (Details the 854-fold increase via “mito-condition” medium, stem cell-based “mitochondria factory,” superior energy output, and accelerated cartilage regeneration in OA animal models)
• Full peer-reviewed paper (Bone Research, 2025): https://t.co/0hvSQz6Q6H (Technical on organelle-tuning, AMPK pathway activation, 854x yield calculation over passages, in vitro ATP boosts in OA chondrocytes, and in vivo mitotherapy showing significant cartilage repair over 12 weeks in mouse OA models)
• PMC full-text/open access: https://t.co/hFH3oIbuoQ (Figures on mitochondrial yield, function, and therapeutic effects in OA chondrocytes/animal models)
Explainer on mitochondrial therapy for cartilage: “New Method Creates 854x More Mitochondria for Cartilage Regeneration” (overview with graphics of the process) https://t.co/fy9jl9LJox
For those who are interested:
search “854x mitochondria cartilage regeneration” for latest; one popular:
https://t.co/Wo8EoEZssj ]
(Note: Direct lab videos are embedded in university/news pages above—check EurekAlert or Nature .
• https://t.co/yt0TU4jmuF [relevant: search “mitochondria osteoarthritis regeneration” for high-view reactions/explainers from med channels]
• General high-engagement: https://t.co/hCLLc0wC7d (adapt from searches; concepts shown via animations of mito transfer boosting chondrocyte energy)
All facts verified from primary sources—no exaggeration.
Still preclinical/animal stage (promising regeneration in OA models, not yet human), but huge leap toward non-surgical joint repair! 🚀
This was the highest volume day on $IBIT, ever, by a factor of nearly 2x, trading $10.7B today. Additionally, roughly $900M in options premiums were traded today, also the highest ever for IBIT. Given these facts and the way $BTC and $SOL traded down in lockstep today (normally SOL trades with beta) + the relatively lower liquidations on CeFi exchanges, this leads me to believe that the nexus of the problem lies with a large IBIT holder. IBIT has become the #1 venue for BTC options trading, so my guess is that a hedge fund trading IBIT options is the culprit.
If you look at the 13F filings for IBIT (I like whalewisdom dot com), you'll find a number of interesting names that have the majority of their fund in IBIT. In fact, there are a few in there (not naming names) that have 100% of their fund in IBIT, which likely means no cross margin. In fact, the biggest reason to set up a fund to hold a single asset would be to isolate margin, so that if the trade blew up, the brokers wouldn't have claim to any other assets.
Interestingly, most of these giant, single asset funds are based in HK.
We know that Asian traders, particularly in China, have been deeply involved in the Silver and Gold trade. Silver was down 20% today, which was the 2nd largest 1 day move in a very long time (largest on Jan 30). We also know that the JPY carry trade has been unwinding at an increasingly rapid pace.
This leads me to think that the culprit for the IBIT blowup today was 1 or more HK-based non-crypto hedge funds. As @FranklinBi pointed out, the fund(s) being non-crypto would explain why no one sniffed them out. They would likely have few/no crypto counterparties, meaning complete isolation from CT.
The last small piece of evidence I have is that I personally know a number of HK-based hedge funds that are holders of $DFDV, which had the worst single down day ever, with a meaningful mNAV decline. The mNAV had been holding steady surprisingly well throughout this pull back until today. One of these fund(s) could have been connected to the IBIT culprit, as I highly doubt a fund taking that large of a position in IBIT and using a single entity structure would only have the one fund.
Now, I could easily see how the fund(s) could have been running a levered options trade on IBIT (think way OTM calls = ultra high gamma) with borrowed capital in JPY. Oct 10th could very well have blown a hole in their balance sheet, that they tried to win back by adding leverage waiting for the "obvious" rebound. As that led to increased losses, coupled with increased funding costs in JPY, I could see how the fund(s) would have gotten more desperate and hopped on the Silver trade. When that blew up, things got dire and this last push in BTC finished them off.
I have no hard evidence here, just some hunches and bread crumbs, but it does seem very plausible. Let's see if some more concrete evidence floats to the surface here soon. The smoking gun will be a large fund fitting this profile filing a 13F showing a giant IBIT holding going to zero. Unfortunately, if a fund had their IBIT position liquidated today, they wouldn't have to disclose the position change until 45 days after the quarter end, so we'd be looking at mid May for the smoking gun from 13F filings most likely.
Hopefully some of you out there with too much time on your hands this weekend can snoop around more. My guess is that word will start to get out, because something of this size is just too hard to hide. Additionally, if the broker was not able to liquidate the fund in time, the broker may have a hole in their balance sheet, which would be even more difficult to hide.
$1,000,000 was settled over the Lightning Network. On January 28th history was made.
We just powered the first publicly reported $1M Lightning transaction between @SD_Markets and @krakenfx in .47 seconds.
The future of institutional Bitcoin settlement is here.
Lightning got boxed in early. "It's for micropayments." That narrative stuck, but it was only ever part of the story.
Lightning is settling million-dollar transactions today. It's time the world sees this network for what it actually is.
This is only the beginning.
Bitcoin moving at the speed it was meant to.
Powered by @voltage_cloud
We've spent 50 years trying to kill cancer cells. What if the answer was never to kill them but to remind them who they are?
Cancer cells aren't foreign invaders. They're your own cells that lost their identity. They stopped differentiating, stopped maturing, and started growing without limits. Cancer doesn't create anything new. It hijacks normal biology.
Researchers at KAIST in South Korea identified three master regulators, MYB, HDAC2, and FOXA2, keeping colon cancer cells locked in a malignant state. When they silenced all three? The cancer cells differentiated back into normal, healthy tissue. MYC and WNT pathways shut down. In mice, tumors shrank significantly.
No chemo. No radiation. Just reprogramming.
Here's what most people will miss: HDAC2 is a histone deacetylase. It compacts DNA and silences tumor suppressor genes. We already use HDAC inhibitors in our protocols. This isn't new to us. But it's powerful validation.
Cancer and aging are the same problem. Cells that no longer serve the body but learned to hijack the immune system to survive. The answer isn't bigger bombs. It's restoration.
Still preclinical. But the direction is exactly right. Kudos to the @kaistpr team. 👏
Win or lose, Saylor swung for the fences.
The world presented him with an opportunity to create and control the largest Bitcoin stack in the world and he grabbed it with both hands.
That is gangster material. Trolls, investors, bag holders, they are all nothing compared to him.
When the dust settles and Bitcoin succeeds, which it most likely will, he will have cemented his name into history in a way that very few will ever be able to do.
He will go down as the tardiest OG. The last one to turn back the clock 10 years late and pull up beside the first whales.
Let the games play out, and I hope he rides this bronc out.
🧵 The cost of everything technology touches is falling toward zero. Yet, we're told prices should rise. Why? Let's dig into the disconnect between tech-driven deflation and our inflationary monetary system. 👇
Bitcoin doesn’t really have a “price”
The general public sees it as a stock/investment so we fell into saying “price” to make it easy
Bitcoin is money though, and money has no price. It has an exchange rate
You wouldn’t say “what is the price of a peso” a
Strategy bought an eye-watering $3.38B of BTC over the past two weeks ($1.25B + $2.13B). Plenty of takes on these moves, but I want to provide some color on what they're doing to the capital structure, which I find to be especially notable.
Firstly, STRC is obviously having its moment in the sun. $119M two weeks ago, $294M this past week—all while STRC stays pinned within 1% of face value.
This $STRC issuance has been in tandem with a large amount of $MSTR ATM . What does this mean, and is this accretive for shareholders?
Most MSTR was sold between 1.0x-1.10x mNAV. This is accretive in net asset terms, however with market cap below the value of BTC holdings, in isolation, it would be negative to BTC/share. However, Saylor is intelligently pairing the MSTR ATM with the STRC ATM. STRC was ~14% the size of MSTR issuance over this period. In BTC per fully-diluted share terms, despite selling of common with BTC below market cap value (while indeed above 1.0x in enterprise value terms), BTC per fully diluted common shares increased over the past two weeks —up 0.4% on the year. So, indeed accretive, but in my view, the bigger story is the focus on deleveraging the convertible bonds to focus on attaining "amplification" through prefs instead.
If we assume constant 92K BTC for consistency, from the start of the year to today:
Converts (less USD) as % of BTC: 9.67% → 9.18%
Prefs (less USD) as % of BTC: 9.19% → 9.36%
Strategy has flipped its outstanding convertible debt with notional prefs, which of course never come due in principal. In just one year.
Why is this being done? Strategy's team has made clear they see the perpetual pref (dubbed "digital credit") as the big idea. The fact that prefs can IPO, with ATMs attached, with no maturity cliff speaks for itself.
But I believe there's an additional motivation potentially: minimizing the gamma effect convertible debt has on the credit spreads of the prefs.
If you correctly view the convertible bonds as debt + an equity call option, at $400 MSTR the weighted delta on the converts was approximately 73%. The market effectively viewed Strategy as having ~$2.18B of effective debt with ~$6.06B that would become equity. This is rough back-of-napkin math, but you can use Black-Scholes to input the convertible bond strikes and first put dates, you can approximate a delta for each bond. In aggregate, you get a weighted average delta.
So yes, while technically $8.2B of debt has been outstanding for almost a year, the market doesn't
treat this as 100% debt—it probabilistically moves with MSTR stock price.
When BTC fell sharply in November and MSTR (as well as all other BTC proxies) followed, the stock price falling essentially partially 'de-equitized' the converts. A move from $400 to $150 is sort of like ~$2.5B more debt becoming senior to the prefs. The delta of the converts—their sensitivity to MSTR price—changed. This change in delta is called gamma.
The point here is that it wasn't necessarily just BTC NAV itself contracting that changed the profile of the prefs in the eyes of some credit investors. It was BTC price moving MSTR price, which impacted the likelihood of conversion of the converts, which impacted the assumed senior liabilities above the prefs.
With the massive purchases in recent weeks, it's clear that Strategy is diligently deleveraging the converts off the balance sheet (relatively), which means the convert gamma will have minimal—and eventually no impact on pref credit spreads.
Having no convertible bonds senior to the prefs should not only improve absolute credit spreads but should diminish credit spread volatility, as the volatility of the size of the assumed senior liabilities above the prefs goes away entirely. This should make prefs like STRC even less volatile, reinforcing the strength and efficiency of the system further.
So to answer the question: yes, this mix of STRC and MSTR issuance is accretive in BTC Yield terms, but I think the bigger story here is the deleveraging of the balance sheet (relatively) of convertible bonds, and it's shifting the focus to pref-style "amplification"—exactly as the MSTR team has stated.
The USD reserve is another recent shift worth noting. It looks to have further dampened credit spread volatility in the prefs by quieting market concerns around dividend coverage and immediate capital raising needs.
Congrats to the Strategy team on having notional prefs surpass converts in just one year.
Wildly impressive.